Management of Reticulation in the Lingular Segment on HRCT

Initial Diagnostic Approach

The European Respiratory Society recommends obtaining detailed exposure history to systematically exclude hypersensitivity pneumonitis, focusing on organic antigen exposures, in patients with reticulation in the lingular segment on HRCT 3
The American Thoracic Society suggests reviewing all medications for fibrogenic drugs including amiodarone, methotrexate, and nitrofurantoin, in patients with interstitial lung disease 4
The European Respiratory Review recommends screening for connective tissue disease with targeted serologies, even in the absence of obvious extrapulmonary manifestations, in patients with reticulation on HRCT 3
Measuring inflammatory markers, including differential blood cell count, C-reactive protein, serum creatinine, and transaminases, is recommended to assess disease activity and progression 3

The Radiological Society of North America recommends that the specific HRCT characteristics of the reticulation determine the diagnostic pathway and urgency of intervention, with subpleural and basal predominant distribution suggesting UIP/IPF pattern 2
The American College of Radiology suggests that absence of ground-glass opacity as the dominant feature, and absence of small airways disease signs, are indicative of UIP pattern 5
Honeycombing may be absent in early disease, but its presence confirms definite UIP pattern, according to the Fleischner Society 6

The American Thoracic Society recommends obtaining spirometry with diffusing capacity to establish baseline lung function and detect subclinical restriction or gas exchange impairment, in patients with interstitial lung disease 4
Normal pulmonary function tests in the context of limited reticulation suggest stable chronic changes rather than active progressive disease, according to the European Respiratory Society 4

The American Journal of Respiratory and Critical Care Medicine recommends that BAL should be performed when HRCT does not show a definite UIP pattern, particularly if hypersensitivity pneumonitis or NSIP is in the differential diagnosis, with lymphocyte predominance >30% arguing strongly against IPF 1
Targeting the BAL site based on HRCT findings, rather than using traditional sites, is recommended to ensure accurate diagnosis, according to the European Respiratory Review 1

The Radiological Society of North America recommends that all cases with indeterminate HRCT patterns require multidisciplinary discussion integrating clinical, radiological, and pathological findings, with referral to an expert center if necessary 2
Expert chest radiologist review is mandatory to confirm key signs of fibrosis and validate the estimated percentage of disease extension, according to the Fleischner Society 8

The European Respiratory Society recommends repeat HRCT in 6-12 months to assess for progression, in patients with stable-appearing changes and normal PFTs 4
Monitoring for development of traction bronchiectasis is recommended, as this indicates disease progression even without change in reticulation extent, according to the Radiological Society of North America 2

The Radiological Society of North America recommends that visual quantification of fibrosis extent must be performed exclusively on HRCT scans, using standardized methods, to determine eligibility for antifibrotic treatment 2
Documenting the percentage of total lung volume affected is necessary to determine treatment eligibility, according to the European Respiratory Society 8